Effects of sarpogrelate, eicosapentaenoic acid and pitavastatin on arterioslcerosis obliterans-related biomarkers in patients with type 2 diabetes (SAREPITASO study)
S Nomura, T Taniura, A Shouzu, S Omoto… - Vascular health and …, 2018 - Taylor & Francis
Background The aim was to evaluate the significance of arteriosclerosis obliterans-related
biomarkers in patients with type 2 diabetes mellitus (T2DM), and to compare the effects of …
biomarkers in patients with type 2 diabetes mellitus (T2DM), and to compare the effects of …
RETRACTED ARTICLE: Effect of rosuvastatin on fasting and postprandial endothelial biomarker levels and microvascular reactivity in patients with type 2 diabetes …
KM Kim, KY Jung, HM Yun, SY Lee, TJ Oh… - Cardiovascular …, 2017 - Springer
Background The cardiovascular benefits of statins have been proven, but their effect on
circulation in small vessels has not been examined fully. We investigated the effect of 20 mg …
circulation in small vessels has not been examined fully. We investigated the effect of 20 mg …
Sarpogrelate hydrochloride decreases cardio-ankle vascular index accompanied by increased serum lipoprotein lipase mass in type 2 diabetic patients
D Nagayama, M Ohira, A Saiki, K Shirai… - International Heart …, 2014 - jstage.jst.go.jp
The 5-hydroxytryptamine2A receptor antagonist sarpogrelate hydrochloride exerts its effect
not only by inhibition of platelet aggregation, but also by some pleiotropic effects. We have …
not only by inhibition of platelet aggregation, but also by some pleiotropic effects. We have …
Correlation between OSAHS and Early Peripheral Atherosclerosis Indices in Patients with Type 2 Diabetes Mellitus in China: A Cross‐Sectional Inpatient Study
X Zhao, X Yu, S Xin, W Zhang… - Journal of Diabetes …, 2021 - Wiley Online Library
Objective: To analyze the differences of early atherosclerosis indices in type 2 diabetes
mellitus (T2DM) patients with different degrees of obstructive sleep apnea‐hypopnea …
mellitus (T2DM) patients with different degrees of obstructive sleep apnea‐hypopnea …
Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus
M Otsuki, K Goya, S Kasayama - Vascular health and risk …, 2005 - Taylor & Francis
Diabetes mellitus is an important risk factor for cardiovascular morbidity and mortality. The
metabolic abnormalities caused by diabetes mellitus induce vascular endothelial …
metabolic abnormalities caused by diabetes mellitus induce vascular endothelial …
Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes
A Bellia, S Rizza, A Galli, R Fabiano, G Donadel… - Atherosclerosis, 2010 - Elsevier
OBJECTIVE: To compare the short-term effects of rosuvastatin and simvastatin on insulin-
resistance and endothelial dysfunction in middle-aged patients with type 2 diabetes and …
resistance and endothelial dysfunction in middle-aged patients with type 2 diabetes and …
Phosphoprotein 1 (osteopontin) gene (rs4754) affects markers of subclinical atherosclerosis in patients with type 2 diabetes mellitus.
A Pleskovič, J Makuc, D Petrovič - International Angiology: a …, 2017 - europepmc.org
Background Our study was designed to test a possible association between polymorphisms
of the SPP1 gene (rs4754, rs28357094) and markers of carotid atherosclerosis (CIMT …
of the SPP1 gene (rs4754, rs28357094) and markers of carotid atherosclerosis (CIMT …
The Clinical Features and Treatment of Arteriosclerosis Obliterane With Diabetes
N Tsushima, H Matsuo, T Hayashi, S Homma - Diabetes, 1996 - Am Diabetes Assoc
The objective of this study was to clarify the differences, if any, in the clinical features
between diabetic and nondiabetic patients with arteriosclerosis obliterane (ASO) and to …
between diabetic and nondiabetic patients with arteriosclerosis obliterane (ASO) and to …
[HTML][HTML] Comparative efficacy of rosuvastatin monotherapy and rosuvastatin/ezetimibe combination therapy on insulin sensitivity and vascular inflammatory response …
JH Han, KH Joung, JC Lee, OS Kim… - Diabetes & …, 2024 - synapse.koreamed.org
Background Type 2 diabetes mellitus (T2DM) induces endothelial dysfunction and
inflammation, which are the main factors for atherosclerosis and cardiovascular disease …
inflammation, which are the main factors for atherosclerosis and cardiovascular disease …
Pravastatin promotes coronary collateral circulation in patients with coronary artery disease
H Nishikawa, S Miura, B Zhang… - Coronary artery …, 2002 - journals.lww.com
Background Previous studies suggested that hydroxymethylglutaryl coenzyme A reductase
inhibitor (statin) promotes collateral circulation in ischemic limbs of rabbits. The present …
inhibitor (statin) promotes collateral circulation in ischemic limbs of rabbits. The present …